Assignee
HETERO RESEARCH FOUNDATION
IN·22 granted patents·24 pending applications·25 citations·filing 2008–2020
Top patents by PatentIndex Score
46 records- 0190US8669265B2Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form BHETERO RESEARCH FOUNDATION·Filed 2013·Granted Mar 11, 2014·8 cites·5 claims
- 0286US10023526B2Process for the preparation of lomitapideHETERO RESEARCH FOUNDATION·Filed 2015·Granted Jul 17, 2018·2 cites·5 claims
- 0379US9175005B2Crystalline hydrochloride salt of darunavirHETERO RESEARCH FOUNDATION·Filed 2014·Granted Nov 3, 2015·3 cites·11 claims
- 0478US9963430B2Process for the preparation of intermediate of dolutegravirHETERO RESEARCH FOUNDATION·Filed 2015·Granted May 8, 2018·2 cites·2 claims
- 0578US9783542B2Process for pralatrexateHETERO RESEARCH FOUNDATION·Filed 2013·Granted Oct 10, 2017·2 cites·3 claims
- 0677US9637516B2Betulinic acid proline derivatives as HIV inhibitorsHETERO RESEARCH FOUNDATION·Filed 2013·Granted May 2, 2017·4 cites·14 claims
- 0776US10336706B2Crystalline form of Eltrombopag free acidHETERO RESEARCH FOUNDATION·Filed 2015·Granted Jul 2, 2019·2 cites·2 claims
- 0869US10934251B2Process for the preparation of lomitapideHETERO RESEARCH FOUNDATION·Filed 2020·Granted Mar 2, 2021·0 cites·13 claims
- 0968US9624172B2Polymorphs of lomitapide and its saltsHETERO RESEARCH FOUNDATION·Filed 2015·Granted Apr 18, 2017·1 cites·16 claims
- 1067US9624207B2Polymorphs of azilsartan medoxomilHETERO RESEARCH FOUNDATION·Filed 2013·Granted Apr 18, 2017·1 cites·21 claims
- 1164US8354541B2Optical purification of esomeprazoleHETERO RESEARCH FOUNDATION·Filed 2008·Granted Jan 15, 2013·0 cites·5 claims
- 1263US9115118B2Process for the resolution of omeprazoleHETERO RESEARCH FOUNDATION·Filed 2014·Granted Aug 25, 2015·0 cites·1 claims
- 1363US2015080420A1Amorphous form of lopinavir and ritonavir mixtureHETERO RESEARCH FOUNDATION·Filed 2014·Application pending·0 cites
- 1461US10206874B2Rufinamide solid dispersionHETERO RESEARCH FOUNDATION·Filed 2013·Granted Feb 19, 2019·0 cites·7 claims
- 1560US9518020B2Process for RegorafenibHETERO RESEARCH FOUNDATION·Filed 2014·Granted Dec 13, 2016·0 cites·4 claims
- 1660US8383811B2Process for preparing efavirenz polymorphHETERO RESEARCH FOUNDATION·Filed 2008·Granted Feb 26, 2013·0 cites·7 claims
- 1759US9580440B2Polymorphs of darunavirHETERO RESEARCH FOUNDATION·Filed 2013·Granted Feb 28, 2017·0 cites·4 claims
- 1857US9770437B2Compositions of eltrombopagHETERO RESEARCH FOUNDATION·Filed 2014·Granted Sep 26, 2017·0 cites·9 claims
- 1957US9345712B2Solid oral compositions of tolvaptanHETERO RESEARCH FOUNDATION·Filed 2013·Granted May 24, 2016·0 cites·6 claims
- 2053US2017304451A1Parenteral compositions of bendamustineHETERO RESEARCH FOUNDATION·Filed 2017·Application pending·0 cites
- 2152US2011263865A1Polymorphs of zolmitriptanHETERO RESEARCH FOUNDATION·Filed 2008·Application pending·0 cites
- 2251US10442769B2Process for the preparation of intermediate of dolutegravirHETERO RESEARCH FOUNDATION·Filed 2018·Granted Oct 15, 2019·0 cites·4 claims
- 2351US9156789B2Process for sorafenib tosylate polymorph IIIHETERO RESEARCH FOUNDATION·Filed 2013·Granted Oct 13, 2015·0 cites·3 claims
- 2451US2016213658A1Pharmaceutical compositions of roflumilast and process for preparation thereofHETERO RESEARCH FOUNDATION·Filed 2014·Application pending·0 cites
- 2551US2010210853A1Process for preparation of candesartan cilexetilHETERO RESEARCH FOUNDATION·Filed 2008·Application pending·0 cites
- 2650US2016310598A1Parenteral compositions of bendamustineHETERO RESEARCH FOUNDATION·Filed 2016·Application pending·0 cites
- 2750US2015141457A1Elvitegravir solid dispersionHETERO RESEARCH FOUNDATION·Filed 2013·Application pending·0 cites
- 2850US2011245497A1Optical resolution of substituted 1, 3-oxathiolane nucleosidesHETERO RESEARCH FOUNDATION·Filed 2008·Application pending·0 cites
- 2949US2017129916A1Novel betulinic proline imidazole derivatives as hiv inhibitorsHETERO RESEARCH FOUNDATION·Filed 2015·Application pending·0 cites
- 3048US2014341992A1Compositions of imatinibHETERO RESEARCH FOUNDATION·Filed 2014·Application pending·0 cites
- 3148US2011212990A1Novel polymorph of moxifloxacin hydrochlorideHETERO RESEARCH FOUNDATION·Filed 2008·Application pending·0 cites
- 3247US2015182629A1Stable compositions of fesoterodineHETERO RESEARCH FOUNDATION·Filed 2013·Application pending·0 cites
- 3347US2014038992A1Methods of administering raltegravir and raltegravir compositionsHETERO RESEARCH FOUNDATION·Filed 2013·Application pending·0 cites
- 3447US2011054186A1Process for eprosartan intermediateHETERO RESEARCH FOUNDATION·Filed 2008·Application pending·0 cites
- 3545US9815806B2Process for cabazitaxelHETERO RESEARCH FOUNDATION·Filed 2015·Granted Nov 14, 2017·0 cites·6 claims
- 3644US2015025040A1Novel polymorphs of fosamprenavir calciumHETERO RESEARCH FOUNDATION·Filed 2012·Application pending·0 cites
- 3743US11053211B2Process for pomalidomideHETERO RESEARCH FOUNDATION·Filed 2015·Granted Jul 6, 2021·0 cites·3 claims
- 3843US2015335653A1Pharmaceutical compositions of linezolidHETERO RESEARCH FOUNDATION·Filed 2015·Application pending·0 cites
- 3943US2017020880A1Pharmaceutical compositions of trametinibHETERO RESEARCH FOUNDATION·Filed 2016·Application pending·0 cites
- 4043US2015224086A1Pharmaceutical Formulations of RufinamideHETERO RESEARCH FOUNDATION·Filed 2013·Application pending·0 cites
- 4142US2015140101A1Solid oral compositions of silodosinHETERO RESEARCH FOUNDATION·Filed 2013·Application pending·0 cites
- 4240US2015119373A1Novel betulinic acid derivatives as hiv inhibitorsHETERO RESEARCH FOUNDATION·Filed 2013·Application pending·0 cites
- 4339US2017051009A1Process for abiraterone acetateHETERO RESEARCH FOUNDATION·Filed 2015·Application pending·0 cites
- 4438US2017119678A1Extended release compositions of carvedilol phosphateHETERO RESEARCH FOUNDATION·Filed 2015·Application pending·0 cites
- 4532US2017007537A1Pharmaceutical compositions of asenapineHETERO RESEARCH FOUNDATION·Filed 2015·Application pending·0 cites
- 4625US2013011477A1Stable Pharmaceutical Composition of ImatinibHETERO RESEARCH FOUNDATION·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HETERO RESEARCH FOUNDATION files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →